Search results for: feed
Member Meeting Recap: cGMPs, Draft Guidance, & More from AAHP
By Eric Foxman. AAHP Secretary | AAHP held a very successful Annual Member Meeting on March 6 using a video-conferencing application…
Read MoreLatest Updates to the HPUS
By Eric L. Foxman, Senior Scientist, HPCUS, AAHP secretary June 4, 2018 Of all the changes implemented by the Homeopathic Pharmacopoeia Convention of the United States (HPCUS) in the past…
Read More2017 Year in Review
2017 was a busy year for AAHP. With a new administration in the White House and key legislative issues heating up, the association had a full plate. But together with…
Read MoreWhat’s New at FDA?
By Mark Land, AAHP president September 1, 2017 I took a course several years ago titled Regulatory Intelligence. The first thing the professor said was, “This course is not designed…
Read MoreWhen Anti-Homeopathy Skeptics Strike
By Deborah Kelly and Alissa Gould, PR Managers, Boiron USA September 1, 2017 It’s typical for skeptics to fire away at anyone who posts or tweets positively about homeopathy. As…
Read More2017 Updates in the Homeopathic Pharmacopeia
By Eric L. Foxman, R.Ph., senior scientist, HPCUS June 1, 2017 Before proceeding to review the major areas of updates in the HPUS, two specific items are of timely interest:…
Read MoreThe Tale of the Contract Manufacturer: A Story Based on an AAHP Member Question
By Eric Foxman, AAHP Secretary Once upon a time, a special creature, the CIAMP (Company Interested in Alternative Medical Products), wanted Phoxman Farmaceuticals (PhoxFarm) to contract manufacture a product for…
Read More2016 Year-In-Review
As 2016 comes to a close and we think back on all the many amazing and unexpected things that have happened, we also note the many activities undertaken and accomplishments…
Read MoreWhat homeopathic manufacturers need to know, and what the FDA wants to see.
By Eric Foxman, AAHP Secretary Late last month, I joined Mark Vermette and Lyn Agostinelli of Halloran Consulting Group as they prepared for our upcoming Compliance Thru Education webinar: Document…
Read MoreFDA’s Quality Metrics Initiative – From Compliance to Performance
By Mark Land, VP Operations and Regulatory Affairs at Boiron The 2012 Food Drug Administration Safety and Innovation Act (FDASIA) gave FDA new tools to encourage high quality manufacturing of…
Read More